F.D.A. Expected to Clear First Coronavirus Vaccine for Young Children
WASHINGTON — The Food and Drug Administration is expected to authorize Pfizer-BioNTech’s coronavirus vaccine for emergency use in children 5 to 11 on Friday, people familiar with the agency’s planning said, a move eagerly anticipated by millions of families looking to protect some of the only remaining Americans left out of the vaccination campaign.
About 28 million children in the group would be eligible to receive one-third of the adult dose, with two injections three weeks apart. If the Centers for Disease Control and Prevention signs off, as is expected, they could start getting shots as early as Wednesday.